ロード中...
HOTAIR‐EZH2 inhibitor AC1Q3QWB upregulates CWF19L1 and enhances cell cycle inhibition of CDK4/6 inhibitor palbociclib in glioma
BACKGROUND: Glioblastoma (GBM) is the most common primary tumor in the brain, and the median survival time for GBM patients is only about 14 months; therefore, there is an urgent need for new and more effective strategies. Since cell cycle disorder is a key factor in tumor progression and immortaliz...
保存先:
| 出版年: | Clin Transl Med |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7240863/ https://ncbi.nlm.nih.gov/pubmed/32508030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ctm2.21 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|